Atticus Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,086
Closed -$256K 181
2026
Q1
$256K Hold
4,086
0.07% 158
2025
Q4
$390K Hold
4,086
0.1% 125
2025
Q3
$399K Buy
4,086
+2,291
+128% +$237K 0.1% 128
2025
Q2
$193K Buy
+1,795
New +$182K 0.05% 172

Other funds holding BSX

Atticus Wealth Management's BSX Position: Q2 2026 in Review

Atticus Wealth Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,086 shares — an estimated $256K sold.

Atticus Wealth Management first reported a position in BSX in Q2 2025 and held it in 4 quarters. The position peaked at $399K in Q3 2025. 179 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Atticus Wealth Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Atticus Wealth Management sold 4,086 Boston Scientific shares in Q2 2026, an estimated $256K.
  • Atticus Wealth Management first reported a position in Boston Scientific in Q2 2025 and held it in 4 quarters.
  • Atticus Wealth Management's Boston Scientific position peaked at $399K in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Atticus Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.